Skip to main content
Clinical Trials/NCT04112901
NCT04112901
Unknown
Not Applicable

Activity, Mobility, Social Functioning, Mental Health and Quality of Life Outcomes in Limited Mobility Transfemoral and Knee Disarticulation Amputees Using Microprocessor-Controlled Knees or Non-Microprocessor Controlled Knees in the United Kingdom: A Cohort Study

University of Derby0 sites330 target enrollmentJanuary 15, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
People With Trans-femoral Amputation
Sponsor
University of Derby
Enrollment
330
Primary Endpoint
Short Form-36 Quality of Life (SF-36)
Last Updated
6 years ago

Overview

Brief Summary

About 21% to 35% of people with limb loss are those who lost their limb at trans-femoral level (i.e. above the knee). The increasing number of diabetes-related limb loss (amputation) and the rising proportion of older adult amputees indicates more amputees with limited mobility in the future. Among other factors, prosthesis success highly depends on the function of the knee joints during daily activities.

Presently, there are two categories of prosthetic knee joints; microprocessor-controlled knees (MPKs) and non-microprocessor-controlled knees (n-MPKs). Whilst the n-MPKs are unable to change the knee stiffness, the MPKs alter the joint stiffness and speed of movement according to the users' walking speed.

Although past studies indicate that MPKs could result in reduced risk of falls, improved balance and activity in limited mobility amputees, there is a lack of strong evidence on the effect of MPKs on community outcomes. The aim of this study is to compare activity, mobility, social functioning, depression, anxiety, and health-related quality of life in limited mobility trans-femoral or through-knee (i.e. knee disarticulation) amputees who are users of MPKs prosthesis with users of a prosthesis with n-MPKs.

Registry
clinicaltrials.gov
Start Date
January 15, 2020
End Date
May 30, 2020
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Reza Safari

Research Fellow

University of Derby

Eligibility Criteria

Inclusion Criteria

  • Unilateral transfemoral amputation or knee disarticulation
  • ≤ K2 mobility grade OR SIGAM grade D or below; i.e. able to walk ≤ 50 meters on level ground,
  • Users of either MPK or N-MPK for at least 6 months prior to the recruitment date.

Exclusion Criteria

  • Not meeting inclusion criteria

Outcomes

Primary Outcomes

Short Form-36 Quality of Life (SF-36)

Time Frame: Baseline

The SF-36 is a validated generic measure of health-related quality of life consisting of eight scales (physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/fatigue, and general health perceptions).

Secondary Outcomes

  • Reintegration to Normal Living Index (RNLI)(Baseline)
  • Special Interest Group in Amputee Medicine (SIGAM)(Baseline)
  • Hospital Anxiety and Depression Scale (HADS)(Baseline)
  • Prosthetic Evaluation Questionnaire (PEQ); Mobility, Social Burden and Residual Limb Health Subscales.(Baseline)

Similar Trials